MedPath

Comparison of Thiopental and Propofol as Anaesteticum During ECT

Not Applicable
Conditions
Depression
Registration Number
NCT00379886
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

Electroconvulsive therapy is the most effective treatment in severe depression and the effect is related to the generalized seizure induced by the treatment. General anesthesia is used during the treatment. Since only a brief period of unconsciousness is required anesthetics with a rapid recovery profile are used.

Methohexital, a barbiturat, is internationally considered "the golden standard", bot other short-acting anesthetics are used. In Denmark the most frequent used anestheticum for ECT is Thiopental, a barbiturat, but also Propofol, a non-barbiturat, is used in many psychiatric departments.

Several studies have shown that Propofol reduce seizure duration in comparison with barbiturates. So far, no studies have demonstrated any clinical implications of the reduced seiziure duration. However, these studies have included rather few patiens, most have been retrospective, and in the only prospective study conducted, uni-lateral ECT was used.

The aim of this study is to compare the clinical effect of ECT in patients anesthesized with either Propofol or Thiopental. The hypothesis is that the shorter duration of seizures found with Propofol as anestheticum will increase the number of treatments needed to clinial respons. Furthermore we want to study differences in EEG-relate parameters previously shown to have prognostic value. Hospitalized patients with major depression, who is to be treated with ECT, are randomized to anesthizia with either Thiopental or Propofol. They are rated with Hamilton depression scale and BDI before treatment, after six treatments and when treatment is concluded. When treatment is ended the patients are furthermore rated with MMSE to evaluate their degree of cognitive impairment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Major depression, hospitalized
Exclusion Criteria
  • age under 18, allergi to anestheticum, out-clinic patients, ECT because of other diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Duration of seizures
Number of ECT-treatments required to treat depression
Amount of energy required to initiate seizure
Secondary Outcome Measures
NameTimeMethod
EEG-related parameters
Changes in seizure-threshold
Cognitive impairment
Haemodynamic parameters

Trial Locations

Locations (1)

Rigshospitalet, Department of Psychiatry

🇩🇰

Blegdamsvej 9, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath